Project Grant R41TR005379
Award Date
6/20/25
Completion Date
6/19/26
Dollars Obligated
$350K
Federal Agency
National Center for Advancing Translational Sciences
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
The federal Project Grant award of $350,000 was provided by the National Center for Advancing Translational Sciences (NCATS), under the CFDA Program 93.350, to Vivosphere LLC in Auburn, AL. The funding will support the development of "Vivospheres", which are tissue-engineered spheroidal models for high-throughput screening. The project aims to establish Vivospheres as a more consistent and flexible 3D cell culture system compared to traditional self-aggregation methods, enabling...
This Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $270,428 to TEO Therapeutics Incorporated, a small disadvantaged business, to develop a biomimetic platform for more efficient pharmaceutical drug development in oncology. The key products and services to be delivered include: Refining and testing a proof-of-concept hardware product line for a Shell-Free Quail Xenograft Assay, optimizing throughput and assessing...
This Project Grant award from the National Cancer Institute (CFDA 93.394, Cancer Detection and Diagnosis Research) to The Regents of the University of California, San Francisco (UCSF) provides $391,703 from May 1, 2025 to April 30, 2028 to develop rapid, sensitive, and reproducible platforms for screening drugs in a preclinical setting using patient-derived breast cancer organoids. The project aims to improve the uniformity, reproducibility, and physiological relevance of organoid models to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Vivosphere LLC aims to develop a more physiologically relevant, consistent, and versatile high-throughput screening (HTS) model to improve the translation rate between preclinical and clinical cancer drug testing. The project will: 1) test additional cancer cell types to demonstrate the platform's broad applicability, 2) explore cryopreservation to reduce response...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant of $274,829 awarded to Rosebud Biosciences Inc. on August 15, 2023 aims to enable the development of new therapies for rare diseases in children. The project objectives are to: (1) Automate the derivation of heart, liver, and brain organoids from human stem cells, and (2) Develop automated machine learning models to detect disease phenotypes in these organoids derived from patients with...
This $900,804 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) federal grant program supports the development and validation of an integrated microphysiological screening platform (MPS) with "virtual human" models to assess chemical toxicity. The key products and services to be delivered include: A 96-well MPS screening platform that combines elements of the awardee's commercial 48-well MPS with highly...
This Project Grant award of $1,207,500.00 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program supports research to advance the understanding of drug absorption processes. The research aims to systematically evaluate the particle drifting effect and de-supersaturation kinetics, both of which are key factors influencing oral drug bioavailability. The project will develop mass transport models, in vitro...
This federal Project Grant award of $295,780.00, funded by the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), supports the development of a high-throughput in vivo screening platform to identify novel probiotic and postbiotic bacterial strains. The awardee, Nemalife Inc., will leverage the nematode Caenorhabditis elegans as a model organism to rapidly screen and characterize bacterial...
This $304,119 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of innovative in vitro 3D atherosclerosis models and high-throughput drug screening assays by Endomimetics LLC. The key objectives are to create an automated, precise approach for fabricating advanced 3D vascular sheet and atherosclerosis models, which will enable efficient, high-throughput testing of drug...
This Project Grant award from the National Institutes of Health's Office of Research Infrastructure Programs (CFDA 93.351 - Research Infrastructure Programs) provides $1,521,607.00 to Emory University to acquire an automated robotic culture system for generating, maintaining, and phenotyping organoid models. The system will be integrated into Emory's Organoid Hub, enabling high-throughput and standardized production of various organoid types including brain, gut, cardiac, and kidney organoids....